Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...
Most people taking popular drugs like Ozempic and Wegovy to lose weight have shed significant pounds. But obesity experts say that roughly 20% of patients — as many as 1 in 5 — may not see robust ...
Vice President Kamala Harris and breakout pop star Chappell Roan were among the most talked-about people this year ...
This year has seen sharp stock moves as companies report financial results and update investors on early and mid-stage drug studies ...
The Federal Trade Commission requires influencers to disclose when a post is a paid advertisement — and a public interest ...
Last year’s study in the journal Obesity had revealed that of people prescribed weight-loss drugs, just 44 per cent were ...
After a stellar FY24 performance, Natco Pharma’s stock has taken a hit. What’s next for the company as it faces crucial ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
On Nov. 26, the Biden administration announced a plan to require Medicare and Medicaid to cover weight loss medications like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback